Based on the results of the expert review of registration materials submitted to the Center under the procedures of registration, re-registration, amendment of registration materials, and materials for conducting clinical studies of medicinal products in Ukraine, by the decision of the Scientific and Technical Council of the Center of 21.03.2024 it was approved to recommend to the MoH of Ukraine:
- for re-registration for an unlimited period – 14 medicinal products
- for registration – 3 substances
- amendments to registration materials (quality changes, safety, efficacy, and pharmacovigilance changes, administrative changes, etc.) – for 179 medicinal products
- amendments to the protocols of international multicentre clinical trials of medicinal products – 14.
The meeting was chaired by the Center's Director Mykhailo Babenko and Deputy Director for Clinical Affairs Mykhailo Lobas.
